ARCHIVES

Regulatory Agencies Get Data For Action Against One Of World’s Most Widely Used Carcinogens

This article is from The Cancer Letter archive.

Vol. 04 No. 40 | October 6, 1978

Download PDF Visit The Full Archive

Related Articles

In Brief: Relocation Of NCI Offices Nearly Complete; Hungary’s Eckhardt UICC President elect

November 4, 1988

Block, Committee Agree; No New PDQ For General Public

January 11, 1985

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004

Acupuncture Eases Radiation-Induced Dry Mouth In Patients

April 24, 2009

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006